Finanzen von UnitedHealth Group Inc (UNH)UNHUnitedHealth Group Inc

UnitedHealth Group Incorporated (UNH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is UnitedHealthCare, accounting for 76.8% of total sales, equivalent to $86.02B. Other significant revenue streams include Optum Rx and Optum Health. Understanding this composition is critical for investors evaluating how UNH navigates market cycles within the Managed Healthcare industry.

Evaluating the bottom line, UnitedHealth Group Incorporated maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.63%, while the net margin is 3.82%. These profitability ratios, combined with a Return on Equity (ROE) of 15.89%, provide a clear picture of how effectively UNH converts its operational activities into shareholder value.

In the context of the broader market, UNH competes directly with industry leaders such as ELV and CI. With a market capitalization of $355.11B, it holds a leading position in the sector. When comparing efficiency, UNH's gross margin of N/A stands against ELV's N/A and CI's 8.58%. Such benchmarking helps identify whether UnitedHealth Group Incorporated is trading at a premium or discount relative to its financial performance.

UnitedHealth has shown robust financial performance, with Q3 revenue of $112.69 billion and a net income of $4.11 billion. The forward P/E ratio is 16.58, suggesting the stock is reasonably valued relative to its expected earnings growth.